Fig. 2.
Fig. 2. Proliferation response of XG cells in the presence of agonist anti-gp130 MoAbs. XG-1 or XG-2 myeloma cells were extensively washed and cultured for 5 days with various concentrations of a mixture (1:1) of agonist anti-gp130 MoAbs or of control murine IgG1 or of IL-6. At the end of the culture, the proliferation was assayed by tritiated thymidine incorporation. XG-1 cells were cultured with B-S12 + B-P8 antibodies and XG-2 cells with B1 + I2 antibodies. Results are the mean ± SD tritiated thymidine incorporation determined on sextuplate culture wells. For some points, the SD was too small to be visible on the graph.

Proliferation response of XG cells in the presence of agonist anti-gp130 MoAbs. XG-1 or XG-2 myeloma cells were extensively washed and cultured for 5 days with various concentrations of a mixture (1:1) of agonist anti-gp130 MoAbs or of control murine IgG1 or of IL-6. At the end of the culture, the proliferation was assayed by tritiated thymidine incorporation. XG-1 cells were cultured with B-S12 + B-P8 antibodies and XG-2 cells with B1 + I2 antibodies. Results are the mean ± SD tritiated thymidine incorporation determined on sextuplate culture wells. For some points, the SD was too small to be visible on the graph.

Close Modal

or Create an Account

Close Modal
Close Modal